Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Methylprednisolone in Moderate to Severe COVID-19
NCT04603729Phase 3Completed
- Sponsor
- Fatima Memorial Hospital
- Start
- May 2020
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone, methylprednisolone injection in coronavirus disease 2019 (COVID-19), sponsored by Fatima Memorial Hospital. Started May 2020; status: completed.
02
Drugs
dexamethasonemethylprednisolone injection
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04603729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04603729.